Page last updated: 2024-10-22

amitriptyline and Malignant Melanoma

amitriptyline has been researched along with Malignant Melanoma in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parker, KA1
Glaysher, S1
Hurren, J1
Knight, LA1
McCormick, D1
Suovouri, A1
Amberger-Murphy, V1
Pilkington, GJ1
Cree, IA1
Khouzam, HR1
Emery, PE1
Reaves, B1

Other Studies

2 other studies available for amitriptyline and Malignant Melanoma

ArticleYear
The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures.
    Anti-cancer drugs, 2012, Volume: 23, Issue:1

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Cell Line, Tumor; Clomipramine; Dose-Response Relat

2012
Secondary mania in late life.
    Journal of the American Geriatrics Society, 1994, Volume: 42, Issue:1

    Topics: Age Factors; Aged; Amitriptyline; Bipolar Disorder; Brain Neoplasms; Diagnosis, Differential; Female

1994